Shri Ahimsa Naturals Ltd
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]
- Market Cap ₹ 520 Cr.
- Current Price ₹ 223
- High / Low ₹ 247 / 126
- Stock P/E 23.6
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 24.3 %
- ROE 18.5 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
Cons
- Promoter holding has decreased over last quarter: -25.6%
- Debtor days have increased from 62.9 to 96.2 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 104 | 78 | 96 | |
| 54 | 51 | 65 | |
| Operating Profit | 50 | 27 | 31 |
| OPM % | 48% | 34% | 32% |
| 2 | 1 | 2 | |
| Interest | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 2 |
| Profit before tax | 51 | 25 | 30 |
| Tax % | 25% | 26% | 26% |
| 38 | 19 | 22 | |
| EPS in Rs | 72.99 | 10.21 | 9.39 |
| Dividend Payout % | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 23% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 19% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Equity Capital | 5 | 18 | 23 |
| Reserves | 60 | 66 | 131 |
| 3 | 14 | 0 | |
| 5 | 5 | 38 | |
| Total Liabilities | 74 | 103 | 193 |
| 28 | 40 | 47 | |
| CWIP | 4 | 8 | 4 |
| Investments | 0 | 0 | 0 |
| 42 | 56 | 142 | |
| Total Assets | 74 | 103 | 193 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| 20 | 6 | 44 | |
| -10 | -19 | -4 | |
| -4 | 10 | 34 | |
| Net Cash Flow | 7 | -4 | 74 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Debtor Days | 39 | 53 | 96 |
| Inventory Days | 122 | 340 | 214 |
| Days Payable | 8 | 18 | 3 |
| Cash Conversion Cycle | 154 | 375 | 307 |
| Working Capital Days | 79 | 133 | 91 |
| ROCE % | 31% | 24% |
Documents
Announcements
-
Appointment
30 September 2025 - AGM approved secretarial auditor and reappointed MD and two WTDs effective July/Aug 2026–2029.
-
Change in Auditors
30 September 2025 - AGM approved MD and two WTD reappointments effective Jul/Aug 2026–2029; secretarial auditor appointed for five years.
-
Shareholders meeting
30 September 2025 - AGM (30 Sep 2025): FY25 revenue ₹9,581L, EBITDA ₹3,227L, net profit ₹2,190L; directors reappointed.
-
Trading Window
29 September 2025 - Trading window closed Oct 1, 2025 until 48 hours after unaudited H1 results for September 30, 2025.
-
Copy of Newspaper Publication
7 September 2025 - Notice published for 35th AGM and remote e-voting on Sep 07, 2025.
Business Profile[1]
The Company is engaged in extracting and manufacturing Caffeine Anhydrous Natural, Green Coffee Bean Extracts (GCE), and Crude Caffeine, and trading in herbal extracts. It supplies food & beverages, nutraceuticals, cosmetics, and pharmaceutical industries.